1. Market Research
  2. > Biotechnology Market Trends
  3. > Competitor Analysis c-Met/HGF Inhibitors

Competitor Analysis c-Met/HGF Inhibitors

  • February 2010
  • -
  • La Merie Publishing

Product description

The Competitive Intelligence Report c-MET/HGF Inhibitors as of February 2010 provides a competitor analysis in the development pipeline of novel emerging inhibitors of c-MET receptor tyrosine kinase (RTK) and its ligand hepatocyte growth factor (HGF) or scatter factor (SF) for treatment of solid tumors. Most of the inhibitors are small molecules, but antibodies are a strongly emerging class of c-Met/HGF antagonists.

The c-MET signalling pathway consists of the mesenchymal epithelial transition factor (c-MET) transmembrane tyrosine kinase receptor and its ligand hepatocyte growth factor (HGF) or scatter factor (SF). Binding of HGF/SF to c-MET activates downstream signalling pathways such as Rho, focal adhesion kinase (FAK) and PI3K. These pathways regulate cancer cell growth, survival angiogenesis, invasion and metastasis. Thus, prevention of c-MET dependent neoplastic processes may provide a means for managing invasive tumors of high metastatic potential. In fact, c-MET/HGF has evolved as an attractive target for the pharmaceutical industry.

At present, at least 16 different molecules including four antibodies are in clinical development and quite a number of projects are in preclinical development. The majority of approaches are directed at inhibiting the c-MET receptor tyrosine kinsase (RTK) by small molecules. The first generation of c-MET RTK inhibitors are dual- or multi-targeting c-MET inhibitors. These multi-target c-MET inhibitors are most advanced in clinical development with two projects in phase III. The next wave of c-MET inhibitors typically are ATP-competitive potent and highly selective c-MET inhibitors with lead compounds in phase II.

The Competitor Analysis c-MET/HGF Inhibitors also provides the corporate R&D pipelines for c-MET/HGF Inhibitors. The report includes a compilation of current active projects in research and development of c-Met/HGF Inhibitors. Competitor projects are listed in a tabular format providing Information on:

* Drug Codes,
* Target / Mechanism of Action,
* Class of Compound,
* Company,
* Product category,
* Indication,
* R&D Stage and
* additional comments with a hyperlink leading to the source of information.

Index

* Selective c-MET/HGF Inhibitors
* Dual- and Multi-Targeting c-MET/HGF Inhibitors
* C-Met/HGF Inhibitory Antibodies

Table Of Contents

Competitor Analysis c-Met/HGF Inhibitors

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Vaccine Markets in the World to 2019 - Market Size, Development, and Forecasts

Vaccine Markets in the World to 2019 - Market Size, Development, and Forecasts

  • $ 23 395
  • Industry report
  • August 2015
  • by Global Research & Data Services Oy

The expansion of the global vaccine industry is forecast to reach 1.5% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 8.6%. Currently, human vaccines ...

Vaccine Markets in Europe to 2019 - Market Size, Development, and Forecasts

Vaccine Markets in Europe to 2019 - Market Size, Development, and Forecasts

  • $ 12 090
  • Industry report
  • August 2015
  • by Global Research & Data Services Oy

The industry report package Vaccine Markets in Europe to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for vaccines ...

2015-2019 Global Molecular Diagnostics and NAT Market: Supplier Shares and Market Segment Forecasts

2015-2019 Global Molecular Diagnostics and NAT Market: Supplier Shares and Market Segment Forecasts

  • $ 9 500
  • Industry report
  • July 2015
  • by Venture Planning Group

This report provides the following data: Geographic Coverage:-          France-          Germany-          Italy-          Japan-          Spain-          ...


Download Unlimited Documents from Trusted Public Sources

DNA Industry in the US

  • September 2015
    6 pages
  • DNA  

  • United States  

View report >

Vaccine Sales Statistics

  • August 2015
    2 pages
  • Vaccine  

  • Europe  

    United Kingdom  

View report >

Vaccine Industry in the US

  • August 2015
    2 pages
  • Vaccine  

  • United States  

    North America  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.